哈洛泽生物

US · HALO #1276 按市值排名上市于 1970

121.84 +0.33 +0.27%

实时 - 追踪5344个代码 - 心跳于170秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

增持

最近一期（2026/Q3）披露持股的机构数量减少了1家。
机构持股总比例上升了1.5个百分点。

机构持股

机构持股比例: 111.64% +1.46pp
机构数量: 795 -1
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund88.02%

Public Company8.99%

Hedge Fund7.17%

Government Pension Fund2.66%

Private Company2.52%

Sovereign Wealth Fund1.31%

Individual/Insider1.06%

Family Office/Trust0.49%

Insurance Company0.34%

主要股东截至 2026-06-30

BlackRock 11.69% · 13.27M 股

Vanguard Capital Management, LLC 5.39% · 6.12M 股

Vanguard Portfolio Management, LLC 4.67% · 5.30M 股

State Street Global Advisors 4.56% · 5.18M 股

Boston Partners Global Investors, Inc. 2.44% · 2.77M 股

Invesco Ltd. 2.31% · 2.62M 股

William Blair Investment Management, LLC 2.27% · 2.57M 股

Geode Capital Management, LLC 2.22% · 2.52M 股

Snyder Capital Management, L.P. 2.11% · 2.40M 股

Morgan Stanley 1.98% · 2.24M 股

Congress Asset Management Company, LLP 2.01% · 2.28M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 27次买入 · 23次卖出

姓名	职务	持股比例
Helen Torley	Chief Executive Officer	0.68%
Michael LaBarre	Senior VP & Chief Technical Officer	0.15%
Mark Snyder	Chief Legal Officer	0.04%
Matthew Posard	Independent Director	0.04%
Nicole LaBrosse	Senior Vice President	0.03%
Bernadette Connaughton	Independent Director	0.03%
Jeffrey Henderson	Independent Chairperson	0.03%
Akiko Moni Miyashita	Independent Director	0.02%
Barbara Duncan	Independent Director	0.01%
Mahesh Krishnan	Independent Director	0.01%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-30	James Daly	Independent Director	Other Acquisition	+1,169	--
2026-09-30	James Daly	Independent Director	Other Derivative Acquisition	+1,775	$106.94
2026-09-30	Matthew Posard	Independent Director	Automatic Disposition	-5,230	$107.17–110.04
2026-09-15	Matthew Posard	Independent Director	Automatic Disposition	-18,996	$106.13–108.99
2026-09-10	Helen Torley	Chief Executive Officer	Derivative Exercise and Sale	-60,000	$18.41–108.67
2026-08-31	Dannielle Appelhans	Director	Other Acquisition	+1,161	--
2026-08-31	Dannielle Appelhans	Director	Other Derivative Acquisition	+1,778	$107.72
2026-08-18	Helen Torley	Chief Executive Officer	Derivative Exercise and Sale	-60,000	$18.41–107.77
2026-08-09	Bernadette Connaughton	Independent Director	Automatic Disposition	-1,626	$102.80
2026-07-07	Helen Torley	Chief Executive Officer	Derivative Exercise and Sale	-1,923	$12.07–80.19
2026-06-30	David Ramsay	Former Chief Financial Officer	Other Derivative Acquisition	+16,232	--
2026-06-30	David Ramsay	Former Chief Financial Officer	Other Derivative Acquisition	+39,823	$77.01
2026-06-30	Bernadette Connaughton	Independent Director	Automatic Disposition	-1,625	$76.40–77.21
2026-06-30	Darren Snellgrove	Chief Financial Officer	Other Derivative Acquisition	+41,554	--
2026-06-30	Darren Snellgrove	Chief Financial Officer	Other Derivative Acquisition	+127,432	$77.01
2026-06-29	David Ramsay	Former Chief Financial Officer	Derivative Exercise and Sale	-5,408	$78.27
2026-06-29	David Ramsay	Former Chief Financial Officer	Derivative Exercise and Retained	+4,592	--
2026-06-28	Mahesh Krishnan	Independent Director	Derivative Exercise and Sale	-7,304	$38.46–75.00
2026-06-11	Mark Snyder	Chief Legal Officer	Derivative Exercise and Sale	-2,715	$69.50
2026-06-11	Mark Snyder	Chief Legal Officer	Derivative Exercise and Retained	+2,319	--

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。